✦ LIBER ✦

PP005—Risk perception and compliance in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors

✍ Scribed by Burdová, K.; Friedecký, D.; Faber, E.; Strojil, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pregnancies in patients with chronic mye

✍ Zhou, Li; You, Jian-Hua; Wu, Wen; Li, Jun-Min; Shen, Zhi-Xiang; Wang, Ai-Hua 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 373 KB

Molecular studies in chronic myeloid leu

✍ Charles L Sawyers 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 997 KB

Safety profiles of second-line tyrosine

✍ Sara M Tinsley 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

A Comparison of Methodologies for Estima

✍ Pennington, B.; Batty, A.J.; Clifton-Brown, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Clinical impact of dose reductions and i

✍ Fabio P. S. Santos; Hagop Kantarjian; Carmen Fava; Susan O’Brien; Guillermo Garc 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Significance of deeper molecular respons

✍ Falchi, Lorenzo; Kantarjian, Hagop M.; Wang, Xuemei; Verma, Dushyant; Quintás-Ca 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB